Colorado BioScience Association Honors State’s Leading Life Sciences Organizations and People at 23rd Annual Awards Celebration, Presented by KBI Biopharma
By: Colorado BioScience Association Date: 11/17/2026
Colorado Governor-Elect Phil Weiser Highlighted Colorado’s Innovation and Leadership in Welcome Remarks; Enveda Named Company of the Year; Think Bioscience and VitriVax Recognized as Rising Stars of the Year; Foresight Diagnostics, a Natera Company, Received Deal of the Year Award
DENVER – Nov. 17, 2026 – Colorado BioScience Association (CBSA) honored the people and organizations strengthening Colorado as a leading center for health innovation at its 23rd Annual Awards Celebration, presented by KBI Biopharma. The sold-out celebration, held November 12 at the Seawell Ballroom at the Denver Center for the Performing Arts, brought together Colorado’s life sciences community under the theme “Centered for Life Sciences.”
“Centered for Life Sciences reflects both where we are and how we work,” said Elyse Blazevich, President & CEO of Colorado BioScience Association and President of Colorado BioScience Institute. “Our honorees show how Colorado’s strategic location in the center of the country supports life sciences growth. Together, they strengthen a community grounded in science and focused on improving lives around the world.”
Remarks by Colorado Governor-Elect Phil Weiser and the Road Ahead
Speaking to Colorado’s life sciences community just one week after the election, Governor-elect Phil Weiser highlighted the exceptional people, resources, and institutions powering Colorado’s leadership in innovation. His remarks, delivered as he begins preparing to lead the state, recognized the strengths that make Colorado a place to pursue new ideas and build companies with national and global impact, and signaled the importance of the sector to Colorado’s economic future.
CBSA Board of Directors Chair Byron Hewett, a life sciences strategic advisor, connected those strengths to the work ahead, outlining how the Colorado Life Sciences Strategic Roadmap will guide the community’s next stage of growth. Scheduled for release in 2027, the roadmap will identify Colorado’s competitive advantages and priorities for investment, helping companies start, scale, manufacture, and stay here as the state works toward becoming a top-five U.S. hub for life sciences. With a new administration taking office, the roadmap arrives at a moment when the community can help shape the state’s priorities from the start.
Colorado’s life sciences ecosystem employs close to 41,000 professionals and generates $52.4 billion in economic impact. The community raised a record $3.2 billion in 2025, supported by significant acquisitions, company financings, and federal funding. The evening recognized the sustained work behind that growth, including investments in manufacturing, workforce development, and a supportive business climate.
CBSA Company of the Year: Enveda
Enveda received CBSA’s prestigious Company of the Year Award, sponsored by BioMed Realty. The Boulder-based company uses artificial intelligence to discover medicines from life’s chemistry, translating molecules found in nature into potential treatments for patients. In September, Enveda raised $311 million in Series E financing, bringing its total capital raised to more than $845 million. The investment followed encouraging early clinical results in atopic dermatitis, asthma, and metabolic health and will support further development of three clinical-stage programs.
Enveda grew from seed-stage to unicorn status in less than five years. Previously recognized by CBSA as a Rising Star of the Year in 2022 and Deal of the Year honoree in 2025, Enveda demonstrates Colorado’s capacity to build globally significant life sciences companies.
CBSA also congratulates Company of the Year finalists OnKure Therapeutics and Watchmaker Genomics.
CBSA Rising Stars of the Year: Think Bioscience and VitriVax
Think Bioscience and VitriVax were named Rising Stars of the Year. Both Boulder companies are translating Colorado research into technologies with the potential to address significant unmet needs.
Think Bioscience uses synthetic biology to discover previously overlooked sites on disease-causing proteins where medicines could bind and change their activity. Its lead program targets the underlying biology of Noonan syndrome. In January, the CU Boulder spinout raised $55 million in an oversubscribed Series A financing to advance its pipeline of potential first-in-class medicines.
VitriVax is developing its ALTA® technology to make vaccines easier to deliver by eliminating refrigeration requirements. The approach could expand access to disease prevention in communities where reliable refrigeration and return visits for care are difficult. This year, the company leased more than 31,000 square feet at BioMed Realty’s Flatiron Park in Boulder to support its continued growth, close to the university research and scientific talent that helped establish the company.
CBSA also recognizes Rising Star of the Year finalist HepQuant.
CBSA’s Deal of the Year Award: Foresight Diagnostics, a Natera Company
Foresight Diagnostics, a Natera company, received CBSA’s 2026 Deal of the Year Award for its acquisition by Natera, completed in December 2025. The transaction included $275 million upfront and up to $175 million in additional milestone payments. Foresight developed an exceptionally sensitive blood test to detect tiny traces of cancer that may remain after treatment. The acquisition pairs the Boulder team’s technology and lymphoma expertise with Natera’s precision medicine capabilities. Foresight relocated to Colorado during the pandemic and grew at Fitzsimons Innovation Community before expanding into its own Boulder facility, demonstrating the role Colorado’s infrastructure and partnerships play in company growth.
Additional Honorees Recognized During CBSA’s 23rd Annual Awards Celebration
Building Momentum Award, Sponsored by Metro Denver EDC: CordenPharma
CordenPharma received the Building Momentum Award for investments that expand Colorado’s role in global pharmaceutical manufacturing. The company’s more than $500 million Boulder expansion will increase production of the complex ingredients used in peptide medicines, with plans to add more than 200 employees. The company also leased 64,000 square feet at BioMed Realty’s Flatiron Park for new development laboratories, connecting early development with large-scale manufacturing. CordenPharma strengthens the state’s talent pipeline through active hiring of biotechnology P-TECH program graduates in partnership with Colorado BioScience Institute. The celebration also featured remarks by Janell Tarma, a P-TECH program graduate who serves as a chemical operator at CordenPharma.
Manufacturing Excellence Award: KBI Biopharma
KBI Biopharma was honored with the Manufacturing Excellence Award for its scientific expertise and community leadership, supporting companies as they advance complex biologic therapies from development into production. In 2026, KBI was named Fill-Finish CDMO of the Year and Best in Class for Cultural Fit in the CDMO Leadership Awards, following recognition in 2025 as a global leader in biologics manufacturing. Its commitment to quality and collaboration strengthens Colorado’s reputation as a center for contract development and manufacturing organizations. KBI’s leadership and support for CBSA also strengthen the partnerships that help the state’s life sciences community thrive.
Educator of the Year, Sponsored by Fisher Scientific: Jayme Sneider, St. Vrain Valley Schools Innovation Center
Jayme Sneider, Bioscience Pathway Manager at the St. Vrain Valley Schools Innovation Center, received the Educator of the Year Award for expanding access to life sciences education and careers. She helped bring the biotechnology P-TECH model to life, enabling students to earn a Frederick High School diploma and a no-cost associate degree through Aims Community College while gaining exposure to bioscience careers. A Fulbright Scholar and advocate for inclusive STEM education, Sneider creates learning experiences connected to employers, hands-on laboratory training, and opportunities to earn industry-recognized credentials.
Institute Leadership Award, Sponsored by Biodesix: John Flahive, Agilent Technologies
John Flahive of Agilent Technologies received the Institute Leadership Award for his commitment to preparing Coloradans for high-demand life sciences careers. Through the Life Sciences Talent Collaborative, he brings employers and workforce partners together to align training with employer needs. His contributions helped shape the Life Sciences Manufacturing 101 and 201 programs and create new pathways into life sciences. Flahive also supports St. Vrain’s biotechnology P-TECH program through internships and meaningful exposure to career opportunities.
Patient Champion of the Year, Sponsored by Genentech: Kristy Kibler, Lupus Colorado
Kristy Kibler of Lupus Colorado was honored as Patient Champion of the Year for strengthening patients’ voices in decisions that affect their health and access to care. Drawing on her background in social work and government relations, she advocates for people living with rare and chronic diseases. Kibler has brought the experiences of people living with lupus directly to Colorado policymakers, addressing medication costs, insurance barriers, and access to treatment. Under her leadership, Lupus Colorado has also worked to preserve access to specialty medications patients depend on.
Volunteer of the Year: Glenn Potter, Higginbotham
Glenn Potter of Higginbotham received the Volunteer of the Year Award for his generous contributions of time and expertise to CBSA and Colorado’s life sciences community. A consistent presence at CBSA events, Potter raises his hand, follows through, and brings a centered, steady presence to the work. His dependable partnership and willingness to contribute wherever needed strengthen CBSA’s ability to serve its members and champion the community.
Legislators of the Year, Sponsored by Brownstein: Senator Judy Amabile, Senator John Carson, Representative Dusty Johnson, and Representative Andrew Boesenecker
CBSA recognized four Legislators of the Year for leadership that supports health innovation, patient access, and Colorado’s competitiveness.
- Senator Judy Amabile (D, District 18 – Boulder, Louisville, Superior, and Gunbarrel), a member of the Joint Budget Committee, was recognized for asking important questions about the effectiveness and impact of the Prescription Drug Affordability Board. She also co-sponsored legislation extending Colorado’s Job Growth Incentive Tax Credit, supporting investment and job creation.
- Senator John Carson (R, District 30 – Douglas County), who serves on the Senate Health and Human Services Committee, was honored for pressing for answers on issues affecting patient access and standing with Colorado’s life sciences community during debates over the 340B drug pricing program. He also co-sponsored the Job Growth Incentive Tax Credit extension.
- Representative Dusty Johnson (R, District 63 – Logan, Morgan, Phillips, Sedgwick, Washington, Weld, and Yuma Counties), a member of the House Health and Human Services Committee, was recognized for making patient advocacy a priority in her first term. As a prime sponsor of legislation to protect rare disease treatments from Prescription Drug Affordability Board upper payment limits, she championed patients with complex medical needs.
- Representative Andrew Boesenecker (D, District 53 – Larimer County), a prime sponsor of the Job Growth Incentive Tax Credit extension, was honored for advancing policies that support company growth and healthcare affordability. He also sponsored legislation to credit qualifying prescription drug expenses toward patients’ out-of-pocket obligations.
Together, the honorees demonstrate the value of bipartisan leadership in maintaining a patient-focused, pro-science business climate.
Centered on Hope
The evening’s keynote fireside chat, “Centered on Hope,” brought the purpose of life sciences innovation into sharp focus: helping patients find answers, regain independence, and imagine a future that once seemed out of reach.
Amanda Piquet, M.D., Director of CU Anschutz’s Autoimmune Neurology Program and Céline Dion Foundation Endowed Chair in Autoimmune Neurology, joined Tara Zier, D.D.S., Founder and CEO of The Stiff Person Syndrome Research Foundation, for a conversation moderated by Blazevich. Piquet, a pioneering physician working on the rare disease brought to global attention by Céline Dion, shared the research perspective, while Zier brought her experience of searching for her own diagnosis, living with an invisible disease, and building a foundation to accelerate progress for people living with stiff person syndrome.
Together, their perspectives demonstrated why patient leadership and scientific expertise must advance hand in hand. The conversation highlighted Colorado’s role in pursuing new treatments for rare diseases and the importance of measuring progress through what patients can reclaim in their daily lives.
“This conversation showed what Colorado’s research leadership means for patients and families,” said Matt Teter, Vice President of Partnerships at Colorado BioScience Association. “Dr. Piquet and Dr. Zier connected the science with the deeply personal reasons we pursue it. Their work reminds us that behind every advance is someone hoping to regain an ability, return to a routine, or see new possibilities for their future.”
Sponsor Support
Colorado BioScience Association thanks the sponsors who made the 23rd Annual Awards Celebration possible: Presenting Sponsor KBI Biopharma; Awards Presentation Sponsors Biodesix, BioMed Realty, Brownstein, Fisher Scientific, Genentech, and Metro Denver EDC; Welcome Reception Sponsors Agilent, Cumming Group, and the University of Colorado Boulder and Anschutz campuses; Awards Champion Sponsors Holland & Hart, Hyde Engineering, Medtronic, Natera, NoCo BioComm, Terumo Blood and Cell Technologies, and Umoja Biopharma; and Awards Supporters AdvaMed and PhRMA. CBSA also thanks the community members who hosted tables.
About Colorado BioScience Association
Colorado BioScience Association (CBSA) creates co-opportunity for the Colorado life sciences community. CBSA champions a collaborative life sciences ecosystem and advocates for a supportive business climate. From concept to commercialization, member companies and organizations drive global health innovations, products and services that improve and save lives. The association leads Capital and Growth, Education and Networking, Policy and Advocacy, and Workforce Cultivation to make its members stronger, together. Learn more: cobioscience.com
# # #
Media Contact
Sheliah Reynolds
Primavera Group for Colorado BioScience Association
(720) 289-4739
